A potent anti-HIV-1 gene therapy agent in a humanised mouse model [ 2015 - ]

Research Grant

Researchers: A/Pr David Harrich (Principal investigator)

Brief description We have shown that a synthetic protein called Nullbasic can protect human cells from becoming infected by the AIDS virus, HIV-1. In this project a gene therapy approach will be used to test if a human immune system modified to contain Nullbasic is protected from HIV-1 in an animal model.

Funding Amount $1,101,141.00

Funding Scheme Project Grants

Notes Standard Project Grant